Johnson & Johnson has announced the pricing of a series of notes with varying maturities and interest rates, as detailed in a pricing term sheet filed on May 13, 2024. The offering includes 4.800% notes due 2029, 4.900% notes due 2031, 4.950% notes due 2034, and 5.250% notes due 2054, with a total size of $4 billion. The notes will pay semi-annual interest starting December 1, 2024, and are priced close to par with slight discounts. The proceeds from the sale, along with other funds, are intended to finance the acquisition of Shockwave Medical, Inc., which is contingent on shareholder and regulatory approvals. The offering is managed by a syndicate of banks, including J.P. Morgan Securities LLC and BofA Securities, Inc. as joint book-running managers. The expected settlement date for the notes is May 20, 2024.

Johnson & Johnson has announced the pricing of a series of notes with varying maturities and interest rates, as detailed in a pricing term sheet filed on May 13, 2024. The offering includes 4.800% notes due 2029, 4.900% notes due 2031, 4.950% notes due 2034, and 5.250% notes due 2054, with a total size of $4 billion. The notes will pay semi-annual interest starting December 1, 2024, and are priced close to par with slight discounts. The proceeds from the sale, along with other funds, are intended to finance the acquisition of Shockwave Medical, Inc., which is contingent on shareholder and regulatory approvals. The offering is managed by a syndicate of banks, including J.P. Morgan Securities LLC and BofA Securities, Inc. as joint book-running managers. The expected settlement date for the notes is May 20, 2024.